Paul Scherrer Institute, Laboratory for Biomolecular Research, CH-5323, Villigen, Switzerland.
Institut für Medizinische Physik und Biophysik (CC2), Charité-Universitätsmedizin Berlin, Charitéplatz 1, D-10117, Berlin, Germany.
Sci Rep. 2016 Jun 28;6:28686. doi: 10.1038/srep28686.
Arrestins desensitize G protein-coupled receptors (GPCRs) and act as mediators of signalling. Here we investigated the interactions of arrestin-1 with two functionally distinct forms of the dim-light photoreceptor rhodopsin. Using unbiased scanning mutagenesis we probed the individual contribution of each arrestin residue to the interaction with the phosphorylated apo-receptor (Ops-P) and the agonist-bound form (Meta II-P). Disruption of the polar core or displacement of the C-tail strengthened binding to both receptor forms. In contrast, mutations of phosphate-binding residues (phosphosensors) suggest the phosphorylated receptor C-terminus binds arrestin differently for Meta II-P and Ops-P. Likewise, mutations within the inter-domain interface, variations in the receptor-binding loops and the C-edge of arrestin reveal different binding modes. In summary, our results indicate that arrestin-1 binding to Meta II-P and Ops-P is similarly dependent on arrestin activation, although the complexes formed with these two receptor forms are structurally distinct.
抑制蛋白使 G 蛋白偶联受体 (GPCR) 脱敏,并作为信号转导的介质。在这里,我们研究了抑制蛋白-1与两种功能不同的暗光光受体视紫红质形式的相互作用。使用无偏扫描诱变,我们探测了每个抑制蛋白残基对与磷酸化脱辅基受体 (Ops-P) 和激动剂结合形式 (Meta II-P) 相互作用的单独贡献。极性核心的破坏或 C-尾的位移增强了与两种受体形式的结合。相比之下,磷酸结合残基 (磷酸感受器) 的突变表明,磷酸化受体 C 末端与 Meta II-P 和 Ops-P 的结合方式不同。同样,在结构域界面内的突变、受体结合环和抑制蛋白 C-边缘的变化揭示了不同的结合模式。总之,我们的结果表明,抑制蛋白-1与 Meta II-P 和 Ops-P 的结合同样依赖于抑制蛋白的激活,尽管与这两种受体形式形成的复合物在结构上是不同的。